Items tagged with Treatment
USAID to reach patients in more than 100 countries with life-saving medicine for drug-resistant tuberculosis (post)
Patients in Georgia suffering from deadly strains of multidrug-resistant tuberculosis (MDR-TB) will soon have access to potentially life-saving medication thanks to a collaboration between the U.S. Agency for International Development (USAID) and Janssen. Nearly 200 patients in Georgia will begin receiving the tuberculosis drug, SIRTURO® (bedaquiline), as part of their treatment program for MDR-TB. Georgia is classified as a high MDR-TB burden country with 48 percent of known TB cases being identified as multidrug-resistant.
WHO publication: Active tuberculosis drug-safety monitoring and management (aDSM) (post)
The World Health Organization (WHO) has recently released a consensus document after a meeting on the essential elements for monitoring the safety of anti-TB drugs (aDSM) in Geneva in July 2015.
Determinants of default from TB treatment among patients with drug-susceptible TB in Karachi, Pakistan: A mixed methods study (post)
Abstract
Child with drug-resistant TB successfully treated at Johns Hopkins Children’s Center (post)
Johns Hopkins Children’s Center specialists report they have successfully treated and put in remission a 2-year-old, now age 5, with a highly virulent form of tuberculosis known as XDR TB, or extensively drug-resistant TB. The case, researchers say, provides the first detailed account of a young child in the United States diagnosed and treated for XDR TB.
India: A daily dose to fight tuberculosis more effectively (post)
Maharashtra and four other states to introduce a daily drug regimen for TB patients next year. Currently, patients are administered medicines on Monday, Wednesday, and Friday.
Tuberculosis: Daily antibiotics recommended to prevent resistant strains (post)
A computer model of tuberculosis has shown that approved treatments prescribing antibiotic doses once or twice a week are more likely to lead to drug resistant strains than are daily antibiotic regimens.
Treatment of tuberculosis (post)
Tuberculosis, a scourge since prehistoric times, affects more than 9 million people and causes the death of 1.5 million people each year. Effective treatment has been available for 60 years, but such treatment takes at least 6 months, and resistance to the drugs, which is increasing throughout the world, threatens the effectiveness of treatment. This review summarizes the theoretical principles of tuberculosis treatment, current therapeutic approaches, areas of uncertainty, and persistent challenges.
Death during MDR-TB treatment more likely in people with HIV and underweight or most drug-resistant patients (post)
People living with HIV, those who are underweight and those with more extensive drug resistance are more likely to die during treatment for multidrug-resistant tuberculosis (MDR-TB), a nine-country study has found. The findings were presented at the 46th Union World Conference on Lung Health in Cape Town last week.
Page 15 of 108 · Total posts: 0
←First 14 15 16 Last→